Literature DB >> 15603242

Angina pectoris: a review of current and emerging therapies.

John O Parker1.   

Abstract

Angina pectoris is a debilitating indication of the presence of ischemic heart disease that affects millions of Americans. Although a number of pharmacologic treatments are available, the annual number of revascularization surgeries continues to rise in the United States. Other management strategies, such as spinal cord stimulation, enhanced external counterpulsation, metabolic modulators, and gene therapy, are being explored.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15603242

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  2 in total

Review 1.  Ranolazine: a review of its use in chronic stable angina pectoris.

Authors:  M Asif A Siddiqui; Susan J Keam
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Enhanced external counterpulsation: A unique treatment for the "No-Option" refractory angina patient.

Authors:  Jose Caceres; Patricia Atal; Rohit Arora; Derek Yee
Journal:  J Clin Pharm Ther       Date:  2021-01-07       Impact factor: 2.512

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.